Insider Transactions in Q2 2024 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
688
-1.29%
|
$14,448
$21.79 P/Share
|
|
Jun 06
2024
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
1,458
-6.78%
|
$30,618
$21.73 P/Share
|
|
May 31
2024
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+21.73%
|
-
|
|
May 31
2024
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+4.65%
|
-
|
|
May 31
2024
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+0.32%
|
-
|
|
May 31
2024
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+24.21%
|
-
|
|
May 31
2024
|
Steve E. Krognes Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+10.07%
|
-
|
|
May 31
2024
|
Erik Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+25.92%
|
-
|
|
May 31
2024
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+36.95%
|
-
|
|
May 31
2024
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+21.73%
|
-
|
|
May 31
2024
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+21.73%
|
-
|
|
May 15
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,674
-1.42%
|
$33,480
$20.39 P/Share
|
|
Apr 15
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.39%
|
$29,988
$18.29 P/Share
|
|
Apr 01
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
92,500
-66.15%
|
$1,850,000
$20.5 P/Share
|